Cosunter(SZ:300436) Zheng Quan Zhi Xing·2025-09-01 11:08Group 1 - The board of directors of Fujian Guangshentang Pharmaceutical Co., Ltd. held its 11th meeting of the 5th session on September 1, 2025, in Fuzhou, Fujian Province, with all 8 directors present [1][2]. - The board approved a proposal regarding the transfer of equity and capital increase of a controlling subsidiary, with a unanimous vote of 8 in favor and no opposition or abstentions [1][2]. - The board also approved a proposal to convene the second extraordinary general meeting of shareholders in 2025, with the same unanimous voting results [1][2]. Group 2 - The details of the proposals and meeting outcomes will be disclosed in the company's announcements published in various financial newspapers and on the official website [2]. - The meeting complied with the requirements of the Company Law and the company's articles of association [1]. - The board meeting was chaired by Chairman Li Guoping [1].